CMAX Clinical Research Revenue and Competitors

Adelaide, SA Australia

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • CMAX Clinical Research's estimated annual revenue is currently $20M per year.(i)
  • CMAX Clinical Research's estimated revenue per employee is $104,563

Employee Data

  • CMAX Clinical Research has 191 Employees.(i)
  • CMAX Clinical Research grew their employee count by 16% last year.

CMAX Clinical Research's People

NameTitleEmail/Phone
1
Chief Financial Officer & Company SecretaryReveal Email/Phone
2
Chief Operations OfficerReveal Email/Phone
3
Chief Operating OfficerReveal Email/Phone
4
Finance and Payroll OfficerReveal Email/Phone
5
Recruitment OfficerReveal Email/Phone
6
Participant Engagement OfficerReveal Email/Phone
7
Training ManagerReveal Email/Phone
8
Clinical Project ManagerReveal Email/Phone
9
Study Start-Up ManagerReveal Email/Phone
10
Clinical Services ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20M19116%N/AN/A
Add Company

What Is CMAX Clinical Research?

Established in 1993, CMAX is one of Australia's largest, longest running and most experienced, dedicated clinical trials unit. Our team specialises in a range of early-phase clinical trials, including first-time in human-studies - of which we've conducted more than 100 to date. With an impressive global regulatory history and a database of more than 13,000 active volunteers, our brand new 50-bed Phase I (through to Phase II-IV) unit includes a 24-bed ambulatory cardiac telemetry monitoring system and is centrally located to Adelaide's Bio-med City. All of our studies are fully ICH GCP compliant and comply with the registration requirements of the US FDA, EMEA, Japanese MHW and Canadian HPB; we have been US FDA-audited.

keywords:N/A

N/A

Total Funding

191

Number of Employees

$20M

Revenue (est)

16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CMAX Clinical Research News

2022-04-20 - Skye Bioscience Engages Clinical Trial Site for Phase 1 Study ...

Skye Bioscience Engages Clinical Trial Site for Phase 1 Study in Agreement with CMAX Clinical Research. April 28, 2022 07:00 ET | Source: Skye Bioscience,...

2022-04-20 - Skye Bioscience Engages Clinical Trial Site for Phase 1 Study ...

This study will be conducted in CMAX's purpose-built independent clinical trial facility in Adelaide, Australia. CMAX is one of Australia's...

2022-04-06 - Recce Pharmaceuticals Announces Phase I Clinical Trial of ...

Recce Pharmaceuticals Announces Phase I Clinical Trial of RECCE® 327 ... study being conducted at Adelaide's CMAX clinical trial facility.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$46M19115%N/A
#2
$76.7M1922%N/A
#3
$70M1946%N/A
#4
$64.7M1976%N/A
#5
$46.4M19823%N/A